Nirosha Yalamandala Bhanu, Chen Pin-Hua, Moorthy Thrinayan, Huynh Thi My Hue, Chiang Wen-Hsuan, Hu Shang-Hsiu
Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan.
Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Pharmaceutics. 2022 Feb 27;14(3):527. doi: 10.3390/pharmaceutics14030527.
Nano-catalytic agents actuating Fenton-like reaction in cancer cells cause intratumoral generation of reactive oxygen species (ROS), allowing the potential for immune therapy of tumor metastasis via the recognition of tumor-associated antigens. However, the self-defense mechanism of cancer cells, known as autophagy, and unsustained ROS generation often restricts efficiency, lowering the immune attack, especially in invading metastatic clusters. Here, a functional core-shell metal-organic framework nanocube (dual MOF) doubling as a catalytic agent and T cell infiltration inducer that programs ROS and inhibits autophagy is reported. The dual MOF integrated a Prussian blue (PB)-coated iron (Fe)-containing metal-organic framework (MOF, MIL88) as a programmed peroxide mimic in the cancer cells, facilitating the sustained ROS generation. With the assistance of Chloroquine (CQ), the inhibition of autophagy through lysosomal deacidification breaks off the self-defense mechanism and further improves the cytotoxicity. The purpose of this material design was to inhibit autophagy and ROS efficacy of the tumor, and eventually improve T cell recruitment for immune therapy of lung metastasis. The margination and internalization-mediated cancer cell uptake improve the accumulation of dual MOF of metastatic tumors in vivo. The effective catalytic dual MOF integrated dysfunctional autophagy at the metastasis elicits the ~3-fold recruitment of T lymphocytes. Such synergy of T cell recruitment and ROS generation transported by dual MOF during the metastases successfully suppresses more than 90% of tumor foci in the lung.
纳米催化剂在癌细胞中引发类芬顿反应,导致肿瘤内活性氧(ROS)生成,从而有可能通过识别肿瘤相关抗原来对肿瘤转移进行免疫治疗。然而,癌细胞的自噬这种自我防御机制以及ROS生成的不持续性常常限制了效率,降低了免疫攻击,尤其是在侵袭性转移簇中。在此,报道了一种功能化的核壳金属有机框架纳米立方体(双MOF),它兼具催化剂和T细胞浸润诱导剂的功能,可调控ROS并抑制自噬。双MOF整合了普鲁士蓝(PB)包覆的含铁金属有机框架(MOF,MIL88)作为癌细胞中可编程的过氧化物模拟物,促进ROS的持续生成。在氯喹(CQ)的辅助下,通过溶酶体去酸化抑制自噬,打破自我防御机制并进一步提高细胞毒性。这种材料设计的目的是抑制肿瘤的自噬和ROS功效,并最终改善T细胞募集以用于肺转移的免疫治疗。边缘化和内化介导的癌细胞摄取提高了双MOF在体内转移性肿瘤中的积累。在转移过程中,有效的催化双MOF整合功能失调的自噬引发了约3倍的T淋巴细胞募集。双MOF在转移过程中运输的T细胞募集和ROS生成的这种协同作用成功抑制了肺部超过90%的肿瘤病灶。
ACS Cent Sci. 2019-9-25
ACS Appl Mater Interfaces. 2021-9-29
J Nanobiotechnology. 2025-9-2
Drug Deliv Transl Res. 2025-8-11
Drug Deliv Transl Res. 2025-1-9
Int J Nanomedicine. 2024
Front Immunol. 2023
Pharmaceutics. 2021-7-28
Br J Cancer. 2021-7
Pharmaceutics. 2021-1-14
Nat Rev Cancer. 2021-3